A new discovery may lead to more effective screening and treatment for patients with a difficult to recognize syndrome characterized by tumor-like growths and a high risk of developing specific cancers. The research is the first in over thirteen years to identify an alternate susceptibility gene for Cowden syndrome and related disorders.